Aegon N.V. — Major Shareholding Notification 2019

Aug 1, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	State Street Global Advisors & Affiliates
Company dealt in	AbbVie Inc.
Class of relevant security to which the dealings being disclosed relate (Note 2)	US$0.01 common stock
Date of dealing	31st July 2019

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	69,025,697	4.66869%
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	N/A
Total	69,025,697	4.66869%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	N/A
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	N/A
Total	N/A

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (Note 5)
Purchase	4,500	66.62
Purchase	200	66.62
Purchase	1,400	66.62
Purchase	1,100	66.62
Purchase	3,300	66.62
Purchase	4,700	66.62
Purchase	500	66.62
Purchase	1,237	66.62
Purchase	500	66.62
Purchase	100	66.62
Purchase	1,000	66.62
Purchase	2,100	66.62
Purchase	200	66.62
Purchase	50,700	66.62
Purchase	13,832	66.62
Purchase	31,616	66.62
Purchase	456	66.62
Purchase	98	66.62
Purchase	1,131,700	66.62
Purchase	1,705	66.62
Purchase	230,700	66.62
Sale	4,200	66.62
Sale	1,300	66.64
Sale	1,000	66.62
Sale	100	66.62
Sale	200	66.62
Sale	500	66.62
Sale	3,300	66.62
Sale	1,400	66.62
Sale	500	66.62
Sale	2,200	66.62
Sale	2,100	66.62
Sale	4,700	66.62
Sale	3,300	66.62
Sale	414	66.62
Sale	400	66.62
Sale	500	66.62
Sale	5,200	66.62
Sale	1,100	66.62
Sale	1,237	66.62
Sale	100	66.62
Sale	100	66.62
Sale	208	66.66
Sale	36,000	66.62
Sale	60,316	66.62
Sale	2,964	66.62
Sale	102	66.62
Sale	237	66.62
Sale	363	66.65
Sale	400	66.62
Sale	1,200	66.65
Sale	3,957	66.62

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)
N/A

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing  varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
N/A

(ii) Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)
N/A

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)
N/A

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
N/A

Is a Supplemental Form 8 attached? (Note 9)	NO
Date of disclosure	01st August 2019
Contact name	Chetan Shah
Telephone number	+44 20 33956564
If a connected EFM, name of offeree/offeror with which connected	N/A
If a connected EFM, state nature of connection (Note 10)	N/A